Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AltaML is a leading North American applied artificial intelligence company that specializes in building and deploying machine learning solutions, with a dedicated focus on the healthcare and life sciences sectors. The company operates through a venture studio model, co-creating AI-driven startups, alongside a services division that provides end-to-end ML development for enterprise clients. In healthcare, AltaML leverages data to improve clinical decision-making, optimize patient pathways, and accelerate pharmaceutical research through predictive analytics. Their notable collaborations include partnerships with global pharmaceutical firms like Boehringer Ingelheim and regional health authorities to implement AI in real-world clinical settings. By integrating with existing health data ecosystems, the company helps organizations transition from retrospective data analysis to proactive, actionable insights. Headquartered in Edmonton, Alberta, AltaML is a central figure in the Canadian AI ecosystem, driving innovation in diagnostic imaging and chronic disease management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AltaML.